Topics

Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018

19:00 EST 1 Feb 2018 | Globe Newswire

EAST RUTHERFORD, N,J., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that fourth quarter and full year 2017 financial results will be released on Thursday, February 8, 2018 before the market opens.

The Company will host a conference call to discuss the financial results.

 Fourth Quarter 2017 Earnings Conference Call 
  
When:Thursday, February 8, 2018 at 8:30 a.m. Eastern Time
 
Dial-in:1-888-394-8218 for U.S.
 1-323-701-0226 for International
 Passcode:  9709552
 
Dial-in Replay:1-888-203-1112 for U.S.
 1-719-457-0820 for International
 Passcode:  9709552
 Available through Thursday, February 15, 2018
 
Webcast:www.cambrex.com

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit www.cambrex.com.

Contact:        
Stephanie LaFiura                                                                              
Investor Relations Associate                                                             
Tel: 201-804-3037                                                      
Email: stephanie.lafiura@cambrex.com  


Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...